NESTL+ S.A. NAMENS-AKTIEN SF -,1/ CH0038863350 /
9/5/2024 10:20:03 AM | Chg. -0.140 | Volume | Bid10:20:03 AM | Ask10:20:03 AM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
94.480EUR | -0.15% | - Turnover: - |
94.480Bid Size: - | 94.800Ask Size: - | 253.13 bill.EUR | - | - |
GlobeNewswire
8/13
Seres Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Updates
GlobeNewswire
8/6
Seres Therapeutics Announces Signing of VOWST™ Asset Purchase Agreement with Nestlé Health Science
GlobeNewswire
7/23
Mondelēz International Names Filippo Catalano Chief Information and Digital Officer
GlobeNewswire
6/12
NFWF Announces $10.2 Million in Grants to Cultivate Conservation Practices on Agricultural Lands
GlobeNewswire
6/6
Seres Therapeutics Enters Into Memorandum of Understanding For Vowst™ Asset Sale to Nestlé Health Sc...
GlobeNewswire
3/26
NESTLE INTERNATIONAL AWARDED OMNIQ A PURCHASE ORDER FOR THE SUPPLY OF RUGGEDIZED IOT EQUIPMENT TO NE...
GlobeNewswire
3/19
VML Augments Digital Commerce Capabilities by Forging Partnership with CommerceIQ’s Unified Artifici...